CDSCO's Sampling Guidelines for Drugs, Cosmetics, & Devices

The Central Drugs Standard Control Organization (CDSCO) has released the final version of its regulatory guidelines for sampling medicines, cosmetics and medical devices by central drug inspectors to simplify and streamline sampling procedures

Cipla and CSIR-CDRI Join Hands To Develop Formulation For Fungal Keratitis

Cipla said it has partnered with CSIR-Central Drug Research Institute to foster a novel ophthalmic detailing for contagious keratitis mutually. The coordinated effort expects to use the consolidated mastery and assets of the two associations to...

European Commission Nods Biogen's Skyclarys To Treat Friedreich's Ataxia

Biogen Inc. announced the European Commission (EC) has authorized Skyclarys (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older. Skyclarys is the first treatment approved within the...

Numab Therapeutics and Ono Pharma Partner To Develop Multi-specific Antibody

Numab Therapeutics AG, an organization creating multi-explicit antibody-based immunotherapies for irritation and cancer disease, and Osaka-settled Research and development situated drug organization, Ono Pharma, both mutually declared a worldwide...

Boehringer's Drug Secures CDSCO Approval For Chronic Kidney Disease

Boehringer Ingelheim's (BI) said its diabetes drug Jardiance (empagliflozin) 10mg measurements structure has now been approved by the Focal Medications Standard Control Association of India for the therapy of ongoing kidney illness (CKD), as an...

Curasight Accelerates Clinical Trials for Five Cancer Indications

Curasight A/S, a clinical development company based in Copenhagen, Denmark, announced that it is accelerating and expanding its clinical treatment strategy by adding new Phase 1/2a trials covering five cancer symptoms

KalVista's Genetic Disease Treatment Triumphs in Late-Stage Study

DelSiTech Ltd., a pharmaceutical development and supply company, and Tolmar International Ltd., a fully integrated pharmaceutical company, have strengthened their partnership by signing a global licensing and development agreement following Tolmar's

Torus Health & Tata 1mg Collaborate for Comprehensive Healthcare

Torus Health has partnered with Tata 1mg to create a unique new solution in the healthcare industry. An innovative initiative by Torus Group, a subsidiary of Cosmea Financial Holdings Pvt Ltd, is about to revolutionize India's health and wellness

IAP's launched Child Health Campaign: 'IAP Ki Baat, Community Ke Saath

The Indian Pediatric Association (IAP) has launched a pioneering program called 'IAP Ki Baat, Community Ke Saath' to engage the community actively and provide valuable information on child health.

© 2025 India Pharma Outlook. All Rights Reserved.